The coArtHA trial—identifying the most effective treatment strategies to control arterial hypertensi...
The coArtHA trial—identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trial
About this item
Full title
Author / Creator
Mapesi, Herry , Gupta, Ravi , Wilson, Herieth Ismael , Lukau, Blaise , Amstutz, Alain , Lyimo, Aza , Muhairwe, Josephine , Senkoro, Elizabeth , Byakuzana, Theonestina , Mphunyane, Madavida , Bresser, Moniek , Glass, Tracy Renée , Lambiris, Mark , Fink, Günther , Gingo, Winfrid , Battegay, Manuel , Paris, Daniel Henry , Rohacek, Martin , Vanobberghen, Fiona , Labhardt, Niklaus Daniel , Burkard, Thilo and Weisser, Maja
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Arterial hypertension is the most prevalent risk factor for cardiovascular disease in sub-Saharan Africa. Only a few and mostly small randomized trials have studied antihypertensive treatments in people of African descent living in sub-Saharan Africa.
In this open-label, three-arm, parallel randomized controlled trial conducted at two rural hospitals in Lesotho and Tanzania, we compare the efficacy and cost-effectiveness of three antihypertensive treatment strategies among participants aged ≥ 18 years. The study includes patients with untreated uncomplicated arterial hypertension diagnosed by a standardized office blood pressure ≥ 140/90 mmHg. The trial encompasses a superiority comparison between a triple low-dose antihypertensive drug combination versus the current standard of care (monotherapy followed by dual treatment), as well as a non-inferiority comparison for a dual drug combination versus standard of care with optional dose titration after 4 and 8 weeks for participants not reaching the target blood pressure. The sample size is 1268 participants with parallel allocation and a randomization ratio of 2:1:2 for the dual, triple and control arms, respectively. The primary endpoint is the proportion of participants reaching a target blood pressure at 12 weeks of ≤ 130/80 mmHg and ≤ 140/90 mmHg among those aged < 65 years and ≥ 65 years, respectively. Clinical manifestations of end-organ damage and cost-effectiveness at 6 months are secondary endpoints.
This trial will help to identify the most effective and cost-effective treatment strategies for uncomplicated arterial hypertension among people of African descent living in rural sub-Saharan Africa and inform future clinical guidelines on antihypertensive management in the region.
Clinicaltrials.gov NCT04129840 . Registered on 17 October 2019 ( https://www.clinicaltrials.gov/ )....
Alternative Titles
Full title
The coArtHA trial—identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trial
Authors, Artists and Contributors
Author / Creator
Gupta, Ravi
Wilson, Herieth Ismael
Lukau, Blaise
Amstutz, Alain
Lyimo, Aza
Muhairwe, Josephine
Senkoro, Elizabeth
Byakuzana, Theonestina
Mphunyane, Madavida
Bresser, Moniek
Glass, Tracy Renée
Lambiris, Mark
Fink, Günther
Gingo, Winfrid
Battegay, Manuel
Paris, Daniel Henry
Rohacek, Martin
Vanobberghen, Fiona
Labhardt, Niklaus Daniel
Burkard, Thilo
Weisser, Maja
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bd1cb16a74cd446da7c107f64c56b478
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bd1cb16a74cd446da7c107f64c56b478
Other Identifiers
ISSN
1745-6215
E-ISSN
1745-6215
DOI
10.1186/s13063-021-05023-z